Biotechnology

Mainz Biomed NV

Mainz Biomed's Quantum Cyber Evaluating Quantum Computing and Cyber Defense Acquisitions

Mainz Biomed NV released FY2024 Q1 earnings on September 26 (EST), actual revenue USD 260.39 K (forecast USD 200 K), actual EPS USD -9.8646

Mainz Biomed NV released FY2024 Semi-Annual Earnings on September 26 (EST), actual revenue USD 520.77 K, actual EPS USD -19.7292

Mainz Biomed NV released FY2025 Q1 earnings on September 26 (EST), actual revenue USD 143.36 K (forecast USD 300 K), actual EPS USD -1.3268 (forecast USD -2.8)

Mainz Biomed NV released FY2025 Q2 earnings on September 26 (EST), actual revenue USD 143.36 K (forecast USD 400 K), actual EPS USD -1.3268 (forecast USD -2.4)

Mainz Biomed NV released FY2025 Semi-Annual earnings on September 26 (EST), actual revenue USD 286.72 K (forecast USD 497 K), actual EPS USD -2.6536

Mainz Biomed NV released FY2024 Q2 earnings on September 26 (EST), actual revenue USD 260.39 K (forecast USD 300 K), actual EPS USD -9.8646

Mainz Biomed NV released FY2024 Q3 earnings on March 31 (EST), actual revenue USD 186.61 K (forecast USD 250 K), actual EPS USD -3.8567

Mainz Biomed NV released FY2022 Annual Earnings on March 31, 2025 (EST), Actual Revenue: USD 529.88K (Forecast: USD 697.5K), Actual EPS: USD -74.5537

Mainz Biomed NV released FY2024 Annual Earnings on March 31 (EST), actual revenue USD 893.99K (forecast USD 1.062M), actual EPS USD -22.3609

Mainz Biomed NV released FY2024 9 Months Earnings on March 31 (EST), actual revenue USD 707.38K, actual EPS USD -23.5859

Mainz Biomed NV released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 186.61 K (forecast USD 300 K), actual EPS USD -3.8567

MAINZ BIOMED N V released FY2023 Annual Earnings on March 31 (EST), actual revenue USD 895.48 K (forecast USD 915.5 K), actual EPS USD -64.7585

The Gabelli Equity Trust Inc.

Cyclerion Therapeutics

PMGC

Axe Compute

Mega Fortune

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

System1

RYTHM

U Power

RenX Enterprises

Kiniksa Pharmaceuticals

MiMedx

Rigel Pharma

CapForce Inc.

OpGen

Vertex Pharma

Argenx

Alnylam Pharma

Beigene

Natera

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Mainz Biomed NV(QUCY.US)

Mainz Biomed NV Stock Performance Chart